PAVmed (PAVM) Short-term Investments (2024 - 2025)

PAVmed (PAVM) posted quarterly Short-term Investments of $299000.0 for Q3 2025, little changed quarter-over-quarter from $299000.0 in Q2 2025.

PAVmed (PAVM) Short-term Investments (2024 - 2025) Analysis & Trends

PAVmed's Short-term Investments history runs 2 years deep, the most recent figure standing at $299000.0 for Q3 2025.

In Q3 2025, Short-term Investments changed N/A year-over-year to $299000.0; the TTM figure through Sep 2025 stood at $299000.0 (changed N/A YoY), while the FY2024 annual figure was $299000.0, changed N/A from the prior year.
Short-term Investments for Q3 2025 stood at $299000.0, roughly flat from $299000.0 in the prior quarter.
The five-year high for Short-term Investments was $299000.0 in Q4 2024, with the low at $299000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	PAVmed	32.48 Mn	28.69 Mn	-89,000.00

Download Data